Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient successfully completed Protocol Fx1B-201.
If female; patient is post menopausal. If male, female partner is post-menopausal. If female is of child bearing potential, willing to use acceptable method of birth control up to 3 months after last dose (included female partners of male participants).
Patient is willing to comply with protocol.
You may not be if
Patient did not successfully complete Fx1B-201.
Chronic use of NSAIDS.
Patient has a clinically significant medication condition that increases risk of study participation.
Patient has received heart or liver transplant.
Clareo Health | Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy
